Lan Qin, Zheng Liang, Zhou Xiaohui, Wu Hong, Buys Nicholas, Liu Zhongmin, Sun Jing, Fan Huimin
Shanghai East Hospital, Tongji University, Shanghai, China.
School of Medicine, Tongji University, Shanghai, China.
Front Cardiovasc Med. 2021 May 20;8:614117. doi: 10.3389/fcvm.2021.614117. eCollection 2021.
High blood urea nitrogen (BUN) is associated with adverse outcomes in patients with cardiac disease risks. However, no study has explored whether BUN can predict the risk of cardiovascular disease (CVD) in the healthy older population. This study aims to explore the incidence and risk factors of CVD among a healthy older population community in China. This study was designed as a cohort study with a 4-year follow-up. We recruited 5,000 older people among 137,625 residents of the Gaohang community. In the baseline, subjects were asked to participate in medical screening and biological tests, and answered survey questions. During the follow-up period (2014-2017), the researchers regularly tested the subjects' indicators and assessment scales. We monitored the occurrence of CVD and explored the relationship between BUN and CVD via a Cox regression analysis. During the follow-up, subjects were newly diagnosed with CVD including heart failure (HF), heart disease events, atrial fibrillation, diabetes, hypertension, metabolic syndrome, and kidney disease. The Cox regression analysis found an association between baseline BUN and incident CVD in female subjects, with higher BUN associated with increased risk of AF in females and kidney disease in both male and females. No association was found between BUN and CVD in male subjects. Current results indicate that BUN is a valuable predictive biomarker of CVD. A higher BUN level (>13.51 mg/dL) is associated with an increased occurrence of HF but a decreased occurrence of diabetes and metabolic symptoms in normal older females.
高血尿素氮(BUN)与有心脏病风险的患者的不良预后相关。然而,尚无研究探讨BUN是否能预测健康老年人群的心血管疾病(CVD)风险。本研究旨在探讨中国一个健康老年人群社区中CVD的发病率及危险因素。本研究设计为一项为期4年随访的队列研究。我们在高行社区的137,625名居民中招募了5000名老年人。在基线时,受试者被要求参加医学筛查和生物学检测,并回答调查问卷问题。在随访期间(2014 - 2017年),研究人员定期检测受试者的指标和评估量表。我们监测CVD的发生情况,并通过Cox回归分析探讨BUN与CVD之间的关系。在随访期间,受试者被新诊断患有CVD,包括心力衰竭(HF)、心脏病事件、心房颤动、糖尿病、高血压、代谢综合征和肾脏疾病。Cox回归分析发现女性受试者基线BUN与新发CVD之间存在关联,较高的BUN与女性房颤风险增加以及男性和女性肾脏疾病风险增加相关。在男性受试者中未发现BUN与CVD之间存在关联。目前的结果表明,BUN是CVD的一种有价值的预测生物标志物。较高的BUN水平(>13.51 mg/dL)与正常老年女性HF发生率增加相关,但与糖尿病和代谢症状发生率降低相关。